Medical News

RSS

Study: Facelift surgery improves appearance and quality of life in most patients

Patients who have undergone a facelift rate themselves as looking an average of 12 years younger after surgery, according to a study in the February issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

2 Feb 2011

Daily Report Global Health Conversations: Reflections on Haiti's health system

January 12 marked one year since a major earthquake struck Haiti killing hundreds of thousands and significantly damaging its capital city, Port-au-Prince. To learn more about how the quake has affected health care in Haiti and get a sense of health priorities moving forward, Jaclyn Schiff of the Kaiser Daily Global Health Policy Report spoke with Wesler Lambert, a Haitian-born physician who has worked with Partners in Health/Zanmi Lasante since 1997.

2 Feb 2011

Harbor BioSciences announces publication of newly discovered anti-inflammatory steroids

Harbor BioSciences, a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory diseases, today announced publication of newly discovered anti-inflammatory steroids naturally present in humans.

2 Feb 2011

Nitrate boosts efficiency of mitochondria

The spinach-eating cartoon character Popeye has much to teach us, new research from the Swedish medical university Karolinska Institutet shows. The muscles' cellular power plants - the mitochondria - are boosted by nitrate, a substance found in abundance in vegetables such as lettuce, spinach and beetroot.

2 Feb 2011

New research: Antioxidants in pecans may prevent development of various diseases

A new research study from Loma Linda University demonstrates that naturally occurring antioxidants in pecans may help contribute to heart health and disease prevention; the results are published in the January 2011 issue of The Journal of Nutrition.

2 Feb 2011

Aphios enters subcontract with SAIC-Frederick to develop phospholipid nanoencapsulated camptothecin

Aphios® Corporation today announced that it has entered into a subcontract with SAIC-Frederick, a subsidiary of Science Applications International Corporation, to develop phospholipid nanoencapsulated camptothecin, Camposomes™, for the treatment of pancreatic and other cancers, supporting the NCI Alliance for Nanotechnology.

2 Feb 2011

Clay County and Paris Community Hospitals select HMS EDIS software suite

HMS EDIS, powered by MEDHOST, a software suite that automates patient care processes for the emergency department (ED), has been selected by Clay County Hospital and Paris Community Hospital.

2 Feb 2011

Research identifies potential reversibility of chronic neurologic disability in stroke survivors

A breakthrough in stroke research identifying the potential reversibility of chronic neurologic disability in stroke survivors has published today. In the February 1, 2011 issue of the journal CNS Drugs the first human results of a new method of targeting chronic brain inflammation years after stroke are reported.

2 Feb 2011

FDA issues reminder about safe use of non-sterile alcohol prep pads

Following a recent recall of potentially contaminated non-sterile alcohol prep pads, the U.S. Food and Drug Administration today reminded health care professionals about the safe use of non-sterile alcohol prep pads to clean and disinfect the surface of the skin.

2 Feb 2011

Multi-national group of researchers announce launch of International Genomics of Alzheimer's Project

The launch of the International Genomics of Alzheimer's Project (IGAP) - a collaboration formed to discover and map the genes that contribute to Alzheimer's disease - was announced today by a multi-national group of researchers including Drs. Lindsay Farrer and Sudha Seshadri at Boston University School of Medicine (BUSM). The collaborative effort, spanning universities from both sides of the Atlantic, will combine the knowledge, staff and resources of four consortia that work on Alzheimer's disease genetics.

2 Feb 2011

Masimo PVI predicts fluid responsiveness with high sensitivity, specificity in ICU patients

Masimo announced today that a new study published in the peer-reviewed journal Critical Care Medicine demonstrates that noninvasive, continuous monitoring of Masimo Pleth Variability Index predicts fluid responsiveness with high sensitivity and specificity in mechanically-ventilated patients in the Intensive Care Unit.

2 Feb 2011

FDA to inspect Lannett's manufacturing facility for review of Morphine Sulfate NDA

Lannett Company, Inc., a manufacturer of generic pharmaceuticals, today announced that it recently met with the U.S. Food and Drug Administration (FDA) to discuss the status of the company's New Drug Application (NDA) for Morphine Sulfate Oral Solution as well as other pending product applications.

2 Feb 2011

New study to address causes and risk factors of ovarian cancer in African American women

University Hospitals Case Medical Center and Case Western Reserve University School of Medicine are conducting an important new study addressing the lack of knowledge about causes and risk factors for ovarian cancer in African American women. The five-year study is funded by the National Cancer Institute through Case Western Reserve University School of Medicine.

2 Feb 2011

Nanotechnology and nanotoxicology

The rapid development of nanotechnology has increased fears about the health risks of nano-objects. Are these fears justified? Do we need a new discipline, nanotoxicology, to evaluate the risks? Empa scientists Harald F. Krug and Peter Wick discuss these questions in the new edition of the journal Angewandte Chemie.

2 Feb 2011

Sanofi-aventis announces GetGoal-X Phase III study of lixisenatide against type 2 diabetes

Zealand Pharma A/S, a biopharmaceutical company dedicated to the discovery and development of innovative peptide drugs, is pleased to announce that its partner, sanofi-aventis, today announced that the GetGoal-X Phase III study of lixisenatide, a once-daily GLP-1 receptor agonist licensed from Zealand Pharma, achieved its primary endpoint of non-inferiority in HbA1c reduction from baseline, compared with exenatide twice-daily.

2 Feb 2011

Viewpoints: On Judge Vinson's decision; Medicaid and long-term care; Doctors' ennui; Insurers' profits

Federal Judge Roger Vinson opens his decision declaring ObamaCare unconstitutional with that citation from Federalist No. 51, written by James Madison in 1788. His exhaustive and erudite opinion is an important moment for American liberty, and yesterday may well stand as the moment the political branches were obliged to return to the government of limited and enumerated powers that the framers envisioned.

2 Feb 2011

Boston-based Research 2.0 begins Viral Genetics coverage, publishes initial report

Boston-based Research 2.0 initiated coverage of Viral Genetics, Inc, and published their initial report today. The report is available on the company's website at www.viralgenetics.com/investors/press-releases/R20Report and is also distributed over the internet and through institutional platforms including FactSet, CapitalIQ, and TheMarkets.com.

2 Feb 2011

New study reports migraine surgery eliminates headache in nearly 30% of patients

Surgery to "deactivate" migraine headaches produces lasting good results, with nearly 90 percent of patients having at least partial relief at five years' follow-up, reports a study in the February issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

2 Feb 2011

Bethany Christian Services creates HIV Adoption Toolkit to educate parents

It is estimated that there are more than one million orphans around the world living with HIV/AIDS. Bethany Christian Services, the nation's largest adoption agency, today announced the creation of the HIV Adoption Toolkit for couples considering adopting children living with HIV/AIDS.

2 Feb 2011

ACP finds diagnostic imaging for low back pain does not improve patients health

The American College of Physicians has found strong evidence that routine imaging for low back pain with X-ray or advanced imaging methods such as CT scan or MRI does not improve the health of patients.

2 Feb 2011

Medical News

Study: Facelift surgery improves appearance and quality of life in most patients

Daily Report Global Health Conversations: Reflections on Haiti's health system

Harbor BioSciences announces publication of newly discovered anti-inflammatory steroids

Nitrate boosts efficiency of mitochondria

New research: Antioxidants in pecans may prevent development of various diseases

Aphios enters subcontract with SAIC-Frederick to develop phospholipid nanoencapsulated camptothecin

Clay County and Paris Community Hospitals select HMS EDIS software suite

Research identifies potential reversibility of chronic neurologic disability in stroke survivors

FDA issues reminder about safe use of non-sterile alcohol prep pads

Multi-national group of researchers announce launch of International Genomics of Alzheimer's Project

Masimo PVI predicts fluid responsiveness with high sensitivity, specificity in ICU patients

FDA to inspect Lannett's manufacturing facility for review of Morphine Sulfate NDA

New study to address causes and risk factors of ovarian cancer in African American women

Nanotechnology and nanotoxicology

Sanofi-aventis announces GetGoal-X Phase III study of lixisenatide against type 2 diabetes

Viewpoints: On Judge Vinson's decision; Medicaid and long-term care; Doctors' ennui; Insurers' profits

Boston-based Research 2.0 begins Viral Genetics coverage, publishes initial report

New study reports migraine surgery eliminates headache in nearly 30% of patients

Bethany Christian Services creates HIV Adoption Toolkit to educate parents

ACP finds diagnostic imaging for low back pain does not improve patients health

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News